title: Thalidomide does not modify the prognosis of plasma cell leukemia patients: experience of a single center.
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Petrucci
authors.forename: Vincenza
authors.initials: V
authors.lastname: Martini
authors.forename: Anna
authors.initials: A
authors.lastname: Levi
authors.forename: Cristiano
authors.initials: C
authors.lastname: Gallucci
authors.forename: Giovanna
authors.initials: G
authors.lastname: Palumbo
authors.forename: Patrizia
authors.initials: P
authors.lastname: Del Bianco
authors.forename: Concetta
authors.initials: C
authors.lastname: Torromeo
authors.forename: Robin
authors.initials: R
authors.lastname: Foà
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D020533:Angiogenesis Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000175:diagnosis* / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D020714:Maximum Tolerated Dose; D008875:Middle Aged; D009101:Multiple Myeloma / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality; D011379:Prognosis; D016879:Salvage Therapy; D016019:Survival Analysis; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide